Role of Free Style Libre-Flash Glucose Monitoring: Glycemic Control of Type-1 Diabetes

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2021 Dec 16

PMID 34912412

Citations 1

Authors

Imad A A Mohamed

Iman M Talaat

Hamed A Alghamdi

Gamal Allam

Affiliations

Soon will be listed here.

Abstract

Background & Objective: Type-1 diabetics (T1D) usually do not meet guidelines for glycaemic control. This study aimed to determine the benefit of free style libre-flash glucose monitoring system (FSL-FGM) in lowering glycated hemoglobin (HbA1c) in poorly controlled T1D patients.

Methods: This prospective two single arm clinical study included 273 T1D patients, and data collected at one, six and 18 months with concomitant extraction of samples for HbA1c basal and at six and 18 months. The study was conducted in Prince Mansour Military Hospital at Taif, Saudi Arabia from June 2017 to November 2018.

Results: HbA1c % was significantly diminished in patients used FSL-FGM at 6 and 18 months. The median percentage difference in HbA1c at 6 and 18 months versus basal was significantly decreased in those using FSL-FGM. Within diabetics using FSL-FGM, the median difference in HbA1c after 18 months was significantly decreased in patients with HbA1c >10% compared to those with HbA1c <10%. Estimated HbA1c by FSL showed a significant correlation with HbA1C assayed in the blood. The snapshot information showed a highly significant difference in average glucose with low significant difference in hypoglycemia parameters. The FSL-FGM provides significant changes in HbA1c in diabetic patients without observed risk for hypoglycemia.

Conclusions: The dynamic way of blood glucose monitoring using FSL-FGM provides improvement in HbA1c in diabetic patients without observed risk for hypoglycemia.

Citing Articles

Impact of the FreeStyle Libre 2 System on Glycaemic Outcomes in Patients with Type 1 Diabetes-Preliminary Study.

Rutkowska K, Los-Stegienta A, Baginski M, Zieba E, Baran A, Zurawska-Klis M Diagnostics (Basel). 2024; 14(16).

PMID: 39202265 PMC: 11354050. DOI: 10.3390/diagnostics14161777.

Technology for the Management of Type 1 Diabetes Mellitus in Saudi Arabia and MENA Region: A Systematic Review.

Al Hayek A, Al Dawish M Curr Diabetes Rev. 2024; 21(6):75-92.

PMID: 38676508 DOI: 10.2174/0115733998295755240416060913.

References

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Kalra S, Gupta Y . Ambulatory glucose profile: Flash glucose monitoring. J Pak Med Assoc. 2015; 65(12):1360-2. View

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R . Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388(10057):2254-2263. DOI: 10.1016/S0140-6736(16)31535-5. View

Jovanovic L, Savas H, Mehta M, Trujillo A, Pettitt D . Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care. 2010; 34(1):53-4. PMC: 3005444. DOI: 10.2337/dc10-1455. View

Miller K, Beck R, Bergenstal R, Goland R, Haller M, McGill J . Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013; 36(7):2009-14. PMC: 3687326. DOI: 10.2337/dc12-1770. View

Dunn T, Hayter G, Doniger K, Wolpert H . Development of the Likelihood of Low Glucose (LLG) algorithm for evaluating risk of hypoglycemia: a new approach for using continuous glucose data to guide therapeutic decision making. J Diabetes Sci Technol. 2014; 8(4):720-30. PMC: 4764240. DOI: 10.1177/1932296814532200. View

Schneider S, Iannotti R, Nansel T, Haynie D, Simons-Morton B, Sobel D . Identification of distinct self-management styles of adolescents with type 1 diabetes. Diabetes Care. 2007; 30(5):1107-12. DOI: 10.2337/dc06-2197. View

Svoren B, Volkening L, Butler D, Moreland E, Anderson B, Laffel L . Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes. J Pediatr. 2007; 150(3):279-85. PMC: 1857326. DOI: 10.1016/j.jpeds.2006.12.009. View

Cheng A . Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction. Can J Diabetes. 2013; 37 Suppl 1:S1-3. DOI: 10.1016/j.jcjd.2013.01.009. View

10.

Ji L, Guo X, Guo L, Ren Q, Yu N, Zhang J . A Multicenter Evaluation of the Performance and Usability of a Novel Glucose Monitoring System in Chinese Adults With Diabetes. J Diabetes Sci Technol. 2016; 11(2):290-295. PMC: 5478018. DOI: 10.1177/1932296816662884. View

11.

Al Hayek A, Robert A, Al Dawish M . Evaluation of FreeStyle Libre Flash Glucose Monitoring System on Glycemic Control, Health-Related Quality of Life, and Fear of Hypoglycemia in Patients with Type 1 Diabetes. Clin Med Insights Endocrinol Diabetes. 2017; 10:1179551417746957. PMC: 5731614. DOI: 10.1177/1179551417746957. View

12.

Wood J, Miller K, Maahs D, Beck R, DiMeglio L, Libman I . Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013; 36(7):2035-7. PMC: 3687259. DOI: 10.2337/dc12-1959. View

13.

Bailey T, Bode B, Christiansen M, Klaff L, Alva S . The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015; 17(11):787-94. PMC: 4649725. DOI: 10.1089/dia.2014.0378. View

14.

Edge J, Acerini C, Campbell F, Hamilton-Shield J, Moudiotis C, Rahman S . An alternative sensor-based method for glucose monitoring in children and young people with diabetes. Arch Dis Child. 2017; 102(6):543-549. PMC: 5466923. DOI: 10.1136/archdischild-2016-311530. View

15.

Beck R, Buckingham B, Miller K, Wolpert H, Xing D, Block J . Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009; 32(11):1947-53. PMC: 2768196. DOI: 10.2337/dc09-0889. View

16.

Miller K, Foster N, Beck R, Bergenstal R, DuBose S, DiMeglio L . Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015; 38(6):971-8. DOI: 10.2337/dc15-0078. View